Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04799054 |
|---|---|
| Brief Title: | A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors |
| First Submitted : | February 26, 2021 |
| First Submitted that Met QC Criteria : | March 11, 2021 |
| First Posted : | March 16, 2021 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 3, 2024 |